Eam Investors, LLC Horizon Therapeutics Public LTD CO Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$67.0 - $84.39 $1.71 Million - $2.16 Million	-25,587 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $537,056 - $777,239	-9,724 Reduced 27.54%	25,587 $1.99 Million
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $1.07 Million - $2.01 Million	35,311 New	35,311 $1.96 Million
Q3 2019 Nov 13, 2019	SELL	$23.0 - $27.97 $1.45 Million - $1.76 Million	-63,088 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $1.44 Million - $1.8 Million	63,088 New	63,088 $1.52 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.